COM:ASTRIATX
Astria Therapeutics
- Stock
Last Close
9.34
22/11 21:00
Market Cap
572.19M
Beta: -
Volume Today
173.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 500K - | |||||||||||
cost of revenue | ||||||||||||
gross profit | 500K - | |||||||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 4.13M - | 6.00M 45.33% | 8.63M 43.94% | 10.11M 17.14% | 8.91M 11.83% | 9.33M 4.68% | 8.77M 5.98% | 11.85M 35.05% | 14.81M 25.01% | 19.24M 29.93% | 25.70M 33.60% | |
selling general and administrative expenses | 4.13M - | 6.00M 45.33% | 8.63M 43.94% | 10.11M 17.14% | 8.91M 11.83% | 9.33M 4.68% | 8.77M 5.98% | 11.85M 35.05% | 14.81M 25.01% | 19.24M 29.93% | 25.70M 33.60% | |
research and development expenses | 13.99M - | 15.69M 12.09% | 23.03M 46.82% | 25.45M 10.51% | 18.68M 26.59% | 17.04M 8.78% | 18.32M 7.48% | 25.59M 39.71% | 15.55M 39.23% | 34.26M 120.32% | 42.13M 22.95% | |
other expenses | 1K - | 3K 200% | 7K 133.33% | 93K 1,228.57% | 32K 65.59% | 176K 450% | -50K 128.41% | -101K 102% | -58K 42.57% | -55K 5.17% | 15.20M 27,734.55% | |
cost and expenses | 18.12M - | 21.68M 19.66% | 31.66M 46.02% | 35.56M 12.32% | 27.59M 22.40% | 26.37M 4.43% | 27.09M 2.72% | 37.44M 38.20% | 30.36M 18.90% | 53.50M 76.23% | 67.83M 26.78% | |
operating expenses | 18.12M - | 21.68M 19.66% | 31.66M 46.02% | 35.56M 12.32% | 27.59M 22.40% | 26.37M 4.43% | 27.09M 2.72% | 37.44M 38.20% | 30.36M 18.90% | 53.50M 76.23% | 67.83M 26.78% | |
interest expense | 206K - | 978K 374.76% | 837K 14.42% | 462K 44.80% | 100K 78.35% | -1.67M - | ||||||
ebitda | -17.80M - | -21.43M 20.40% | -31.65M 47.70% | -34.83M 10.03% | -26.60M 23.63% | -25.65M 3.56% | -26.27M 2.40% | -37.44M 42.52% | 134.26M 458.64% | -53.50M 139.85% | -67.83M 26.78% | |
operating income | -18.12M - | -21.68M 19.66% | -31.66M 46.02% | -35.56M 12.32% | -27.09M 23.80% | -26.37M 2.67% | -27.09M 2.72% | -37.44M 38.20% | -194.98M 420.84% | -53.50M 72.56% | -67.83M 26.78% | |
depreciation and amortization | 320K - | 248K 22.50% | 202K 18.55% | 395K 95.54% | 304K 23.04% | 119K 60.86% | 821K 589.92% | 329.23M - | ||||
total other income expenses net | 1K - | 3K 200% | 7K 133.33% | 93K 1,228.57% | 32K 65.59% | 176K 450% | 795K 351.70% | 135K 83.02% | 64K 52.59% | 1.67M 2,507.81% | -5.06M 403.18% | |
income before tax | -18.12M - | -21.88M 20.79% | -32.63M 49.10% | -36.06M 10.51% | -27.36M 24.12% | -25.87M 5.46% | -26.29M 1.64% | -37.30M 41.86% | -194.91M 422.55% | -51.83M 73.41% | -72.89M 40.62% | |
income tax expense | 209K - | 783K 274.64% | 930K 18.77% | 494K 46.88% | 601K 21.66% | -50K 108.32% | -236K 372% | -164.74M 69,704.66% | -1.67M 98.99% | |||
net income | -18.12M - | -21.88M 20.79% | -32.63M 49.10% | -36.06M 10.51% | -27.36M 24.12% | -25.87M 5.46% | -26.24M 1.44% | -37.06M 41.23% | -30.17M 18.59% | -50.16M 66.26% | -72.89M 45.30% | |
weighted average shs out | 144.42K - | 144.42K 0% | 134.03K 7.19% | 270.50K 101.82% | 361.36K 33.59% | 842.47K 133.14% | 1.87M 121.55% | 3.06M 63.87% | 8.93M 191.81% | 14.62M 63.81% | 30.12M 106.03% | |
weighted average shs out dil | 144.42K - | 144.42K 0% | 134.03K 7.19% | 270.50K 101.82% | 361.36K 33.59% | 842.47K 133.14% | 1.87M 121.55% | 3.06M 63.87% | 8.93M 191.81% | 14.62M 63.81% | 30.12M 106.03% | |
eps | -125.45 - | -151.53 20.79% | -243.45 60.66% | -133.31 45.24% | -75.73 43.19% | -30.71 59.45% | -14.06 54.22% | -12.12 13.80% | -3.38 72.11% | -3.43 1.48% | -2.42 29.45% | |
epsdiluted | -125.45 - | -151.53 20.79% | -243.45 60.66% | -133.31 45.24% | -75.73 43.19% | -30.71 59.45% | -14.06 54.22% | -12.12 13.80% | -3.38 72.11% | -3.43 1.48% | -2.42 29.45% |
All numbers in USD (except ratios and percentages)